[Induction of ovulation in 1985].
There are many methods that can be used to induce ovulation when there is a fault in ovulation in patients who have normal prolactin levels. These are: Bringing the weight to a normal level. Giving Clomiphene. Giving Tamoxifen. Giving cyclofenil and bromocriptine, which really have no more effect than giving a placebo. Giving gonadotrophins in a classical way. This is very useful where there is hypogonadic amenorrhoea but much less useful when the failure of ovulation occurs with normal gonadic function. It is accompanied by a risk of multiple pregnancies and of hyperstimulation, which should be monitored by ultrasound very strictly so that it cannot become too serious. The use of purified FSH which theoretically should be more adequate, at least in cases where the gonadic function is normal in spite of failure of ovulation. Pulsatile administration of LHRH, which in cases of hypothalamic amenorrhoea carries less total risk than giving gonadotrophins. Finally, wedge resection of the ovaries which is reversed for polycystic ovaries that are larger than normal in size, and allied methods. The first choice for hypogonadic hypothalamic amenorrhoea would seem to be the LHRH pump; and for failure of ovulation with normal gonadic function Clomiphene or Tamoxifen. When anti-oestrogens fail to correct these latter cases one can choose according to the case between gonadotrophins, choosing if possible pure FSH, and/or wedge resection. In the last resort in these cases the LHRH pump can be used. The frequent failure of these methods show that perhaps it is possible to create a hypogonadotrophic hypogonadism by giving agonists for a long time or antagonists to LHRH in such a way that a second attempt can be made to induce ovulation using gonadotrophins in better conditions of efficacy and safety.
D000568:Amenorrhea / Q000628:therapy; D000858:Anovulation / Q000209:etiology / Q000628:therapy*; D002996:Clomiphene / Q000627:therapeutic use; D003506:Cyclofenil / Q000627:therapeutic use; D004836:Epimestrol / Q000627:therapeutic use; D005260:Female; D005640:Follicle Stimulating Hormone / Q000627:therapeutic use; D007987:Gonadotropin-Releasing Hormone / Q000627:therapeutic use; D006801:Humans; D007006:Hypogonadism / Q000150:complications; D007018:Hypopituitarism / Q000150:complications; D007027:Hypothalamic Diseases / Q000150:complications; D008596:Menotropins / Q000627:therapeutic use; D009765:Obesity / Q000150:complications; D010053:Ovary / Q000601:surgery; D010062:Ovulation Induction / Q000379:methods*; D013629:Tamoxifen / Q000627:therapeutic use; D013851:Thinness / Q000150:complications
D013629:Tamoxifen; D002996:Clomiphene; D007987:Gonadotropin-Releasing Hormone; D008596:Menotropins; D004836:Epimestrol; D005640:Follicle Stimulating Hormone; D003506:Cyclofenil
L'induction de l'ovulation en 1985.